Funding for this research was provided by:
National Institutes of Health (NS084412, P01AG019724, P50AG023501)
Received: 23 September 2021
Accepted: 26 September 2021
First Online: 18 October 2021
: All animals were cared for in accordance with the guidelines of the National Institutes of Health and procedures were approved by the Stanford University School of Medicine Institutional Animal Care and Use Committees. Human tissue samples from patients with AD and controls were provided by the UCSF Neurodegenerative Disease Brain Bank. Informed consent to undergo autopsy was provided by patients and/or their surrogates, following the principles outlined in the Declaration of Helsinki.
: Not applicable.
: S.G and B.L are co-founders and Scientific Advisors of Cerepeut Inc.